Please login to the form below

Not currently logged in


This page shows the latest VIR-7831 news and features for those working in and with pharma, biotech and healthcare.

GSK, Vir’s COVID-19 mAb scores FDA emergency use approval

GSK, Vir’s COVID-19 mAb scores FDA emergency use approval

The EUA clears sotrovimab – previously known as VIR-7831 – for the treatment of mild-to-moderate COVID-19 in high-risk adults and certain paediatric patients who have a positive ... In addition to the positive phase 3 results, GSK and Vir said

Latest news

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...